Skip to main content

Plasma-Lyte 56 and 5% Dextrose Disease Interactions

There are 2 disease interactions with Plasma-Lyte 56 and 5% Dextrose (lvp solution with potassium).

Major

Sodium salts (applies to Plasma-Lyte 56 and 5% Dextrose) sodium/water imbalance

Major Potential Hazard, Moderate plausibility. Applicable conditions: Fluid Retention, Congestive Heart Failure

Sodium chloride can induce sodium and water retention and result in hypernatremia, hypokalemia, edema and aggravation of congestive heart failure. Therapy with sodium- containing agents should be administered with extreme caution, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states where there is edema with sodium retention. Clinical monitoring of acid/base balance and electrolytes prior to, during, a following completion of therapy with sodium- containing agents is recommended.

References

  1. "Product Information. Megace (megestrol)." Bristol-Myers Squibb PROD (2001):
  2. "Product Information. Calcibind (cellulose sodium phosphate)." Mission Pharmacal Company PROD (2001):
  3. "Product Information. Sodium Benzoate (sodium benzoate)." Taylor Pharmaceuticals PROD (2001):
Moderate

LVP solution with potassium (applies to Plasma-Lyte 56 and 5% Dextrose) hyperkalemia

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction

Solutions containing potassium ions should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.

Plasma-Lyte 56 and 5% Dextrose drug interactions

There are 64 drug interactions with Plasma-Lyte 56 and 5% Dextrose (lvp solution with potassium).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer